PMX endotoxin removal in the clinical practice: Results from the EUPHAS trial

Contributions to Nephrology

Volumn 167, Issue , 2010, Pages 83-90

  Antonelli, Massimo ^a   Fumagalli, Roberto ^b   Cruz, Dinna N ^c,d   Brienza, Nicola ^e   Giunta, Francesco ^f  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c San Bortolo Hospital   (Spain)

^d International Renal Research Institute (IRRIV)   (Spain)

^e UNIVERSITY OF BARI   (Italy)

^f UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; OXYGEN; POLYMYXIN B;

ARTICLE; BLOOD; BLOOD PRESSURE; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HEART CONTRACTION; HEMOPERFUSION; HUMAN; INFECTION; METHODOLOGY; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE;

BLOOD PRESSURE; ENDOTOXINS; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMOPERFUSION; HUMANS; INFECTION; MULTICENTER STUDIES AS TOPIC; MULTIPLE ORGAN FAILURE; MYOCARDIAL CONTRACTION; OXYGEN; POLYMYXIN B; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS; SHOCK, SEPTIC; SURVIVAL RATE;

EID: 84926080571     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000315922     Document Type: Article

References (21)

1. Marshall JC, Foster D, Vincent JL, et al: Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 2004;190: 527-534.
2. Opal SM, Glück T: Endotoxin as a drug target. Crit Care Med 2003;31(Suppl 1): S57-S64.
3. Kellum JA: A targeted extracorporeal therapy for endotoxemia: the time has come. Crit Care 2007;11:137.
4. Shoji H, Tani T, Hanasawa K, Kodama M: Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application. Ther Apher 1998;2: 3-12.
5. Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V, Lentini P, Nalesso F, Ueno T, Ranieri VM, Ronco C: Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 2007;11:R47.
6. Cruz DN, Antonelli M, Fumagalli R, et al: Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009;301:2445-2452.
7. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure: on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-710.
8. Jones AE, Trzeciak S, Kline JA: The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 2009;37:1649-1654.
9. Perego AF, Morabito S, Graziani G, Casella GP, Parodi O: Polymyxin-B direct hemo perfusion (PMX-DHP) in gram negative sepsis (in Italian). G Ital Nefrol 2006;23(Suppl 36):S94-S102.
10. Ruberto F, Pugliese F, D'Alio A, et al: Clinical effects of direct hemoperfusion using a polymyxin-B immobilized column in solid organ transplanted patients with signs of severe sepsis and septic shock: a pilot study. Int J Artif Organs 2007;30:915-922.
11. Vincent JL, Laterre PF, Cohen J, et al: A pilot controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005;23:400-405.
12. Cantaluppi V, Assenzio B, Pasero D, et al: Polymyxin- B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med 2008;34:1638-1645.
13. Nakamura T, Kawagoe Y, Matsuda T, Ueda Y, Koide H: Effects of polymyxin B-immobilized fiber on urinary N-acetyl- B-glucosaminidase in patients with severe sepsis. ASAIO J 2004;50:563-567.
14. Esteban A, Frutos-Vivar F, Ferguson ND, et al: Noninvasive positive-pressure ventilation for respiratory failure after extubation. N Engl J Med 2004;350:2452-2460.
15. Lau WY, Leung TW, Ho SK, et al: Adjuvant intraarterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 1999;353:797-801.
16. Pocock SJ: Clinical Trials: A Practical Approach. Chichester, Wiley, 1983.
17. Kellum JA, Uchino S: International differences in the treatment of sepsis: are they justified? JAMA 2009;301:2496-2497.
18. Vincent JL: Polymyxin B hemoperfusion and mortality in abdominal septic shock. JAMA 2009;302:1968.
19. Amaral AC: Polymyxin B hemoperfusion and mortality in abdominal septic shock. JAMA 2009;302:1968-1969.
20. Kida Y: Polymyxin B hemoperfusion and mortality in abdominal septic shock. JAMA 2009;302:1969.
21. Antonelli M, Giunta F, Ronco C: Polymyxin B hemoperfusion and mortality in abdominal septic shock - reply. JAMA 2009;302:1969-1970.